Inventor · disambiguated record
Colin Gegg
Also filed as: GEGG COLIN · GEGG COLIN V · GEGG COLIN V JR · GEGG JR COLIN V
36 granted patents·12 pending applications·1,487 citations·filing 1997–2024
98Inventor score
Top patents by PatentIndex Score
48 records- 0198US7442778B2Modified Fc moleculesAMGEN INC·Filed 2005·Granted Oct 28, 2008·140 cites·14 claims
- 0297US7750128B2Modified Fc moleculesAMGEN INC·Filed 2008·Granted Jul 6, 2010·73 cites·18 claims
- 0397US7662931B2Modified Fc moleculesAMGEN INC·Filed 2008·Granted Feb 16, 2010·60 cites·18 claims
- 0497US6586398B1Chemically modified novel erythropoietin stimulating protein compositions and methodsAMGEN INC·Filed 2000·Granted Jul 1, 2003·396 cites·5 claims
- 0597US6420339B1Site-directed dual pegylation of proteins for improved bioactivity and biocompatibilityAMGEN INC·Filed 1998·Granted Jul 16, 2002·288 cites·4 claims
- 0696US8008453B2Modified Fc moleculesAMGEN INC·Filed 2006·Granted Aug 30, 2011·55 cites·19 claims
- 0796US7655765B2Modified Fc moleculesAMGEN INC·Filed 2008·Granted Feb 2, 2010·42 cites·18 claims
- 0896US7655764B2Modified Fc moleculesAMGEN INC·Filed 2008·Granted Feb 2, 2010·42 cites·18 claims
- 0995US9102731B2Human CGRP receptor binding proteinsBOONE THOMAS C·Filed 2009·Granted Aug 11, 2015·39 cites·15 claims
- 1095US7833979B2Toxin peptide therapeutic agentsAMGEN INC·Filed 2006·Granted Nov 16, 2010·45 cites·31 claims
- 1195US7750127B2Modified Fc moleculesAMGEN INC·Filed 2008·Granted Jul 6, 2010·37 cites·18 claims
- 1295US7645861B2Modified Fc moleculesAMGEN INC·Filed 2008·Granted Jan 12, 2010·38 cites·18 claims
- 1394US8907071B2Toxin peptide therapeutic agentsSULLIVAN JOHN K·Filed 2010·Granted Dec 9, 2014·61 cites·24 claims
- 1493US8420779B2Compositions and methods for producing bioactive fusion proteinsWALKER KENNETH W·Filed 2008·Granted Apr 16, 2013·18 cites·18 claims
- 1591US9862771B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2015·Granted Jan 9, 2018·8 cites·36 claims
- 1691US2025129172A1Human cgrp receptor binding proteinsAMGEN INC·Filed 2024·Application pending·0 cites
- 1789US7834164B2DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expressionAMGEN INC·Filed 2007·Granted Nov 16, 2010·9 cites·8 claims
- 1889US7820623B2Conjugated toxin peptide therapeutic agentsAMGEN INC·Filed 2007·Granted Oct 26, 2010·10 cites·23 claims
- 1985US8541201B2Thrombopoietic compoundsMIN HOSUNG·Filed 2011·Granted Sep 24, 2013·9 cites·4 claims
- 2085US8043829B2DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expressionAMGEN INC·Filed 2007·Granted Oct 25, 2011·6 cites·19 claims
- 2184US8168592B2CGRP peptide antagonists and conjugatesGEGG JR COLIN V·Filed 2006·Granted May 1, 2012·23 cites·11 claims
- 2282US7910102B2Methods of using conjugated toxin peptide therapeutic agentsAMGEN INC·Filed 2007·Granted Mar 22, 2011·4 cites·12 claims
- 2380US9279013B2FGF-21 mutants comprising polyethylene glycol and uses thereofWALKER KENNETH W·Filed 2009·Granted Mar 8, 2016·3 cites·53 claims
- 2479US7262166B2Chemically modified novel erythropoietin stimulating protein compositions and methodsAMGEN INC·Filed 2003·Granted Aug 28, 2007·10 cites·16 claims
- 2578US5900404AChemical modification of proteins to improve biocompatibility and bioactivityAMGEN INC·Filed 1997·Granted May 4, 1999·30 cites·3 claims
- 2677US12134652B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2020·Granted Nov 5, 2024·0 cites·12 claims
- 2777US12122841B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2020·Granted Oct 22, 2024·0 cites·18 claims
- 2877US7981425B2Thrombopoietic compoundsAMGEN INC·Filed 2007·Granted Jul 19, 2011·2 cites·1 claims
- 2975US6017876AChemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivityAMGEN INC·Filed 1998·Granted Jan 25, 2000·24 cites·3 claims
- 3073US11266744B2Modified Fc moleculesAMGEN INC·Filed 2018·Granted Mar 8, 2022·0 cites·24 claims
- 3172US2009048149A1Antagonists of the bradykinin B1 receptorAMGEN INC·Filed 2008·Application pending·0 cites
- 3268US8288339B2GLP-1 compoundsGEGG JR COLIN VICTOR·Filed 2007·Granted Oct 16, 2012·2 cites·7 claims
- 3368US6420340B2Chemical modification of proteins to improve biocompatibility and bioactivityAMGEN INC·Filed 2000·Granted Jul 16, 2002·2 cites·6 claims
- 3468US2008206184A1Chemically Modified Protein Compositions and MethodsAMGEN INC·Filed 2008·Application pending·0 cites
- 3565US8288351B2Antagonists of the bradykinin B1 receptorNG GORDON·Filed 2008·Granted Oct 16, 2012·0 cites·14 claims
- 3665US8278280B2Antagonists of the bradykinin B1 receptorNG GORDON·Filed 2008·Granted Oct 2, 2012·0 cites·14 claims
- 3764US2018142029A1Human cgrp receptor binding proteinsAMGEN INC·Filed 2017·Application pending·0 cites
- 3861US6204247B1Chemical modification of proteins to improve biocompatibility and bioactivityAMGEN INC·Filed 1999·Granted Mar 20, 2001·11 cites·5 claims
- 3960US2013071410A1Human CGRP Receptor Binding ProteinsBOONE THOMAS C·Filed 2012·Application pending·0 cites
- 4059US2013217625A1Compositions and methods for producing bioactive fusion proteinsAMGEN INC·Filed 2013·Application pending·0 cites
- 4159US2005215710A1Chemically modified protein compositions and methodsGEGG COLIN V JR·Filed 2005·Application pending·0 cites
- 4259US2013209466A1Compositions and methods for producing bioactive fusion proteinsAMGEN INC·Filed 2013·Application pending·0 cites
- 4356US10188740B2Modified Fc moleculesAMGEN INC·Filed 2015·Granted Jan 29, 2019·0 cites·33 claims
- 4456US2006264377A1Chemically modified novel erythropoietin stimulating protein compositions and methodsAMGEN INC·Filed 2006·Application pending·0 cites
- 4549US9114175B2Modified Fc moleculesGEGG COLIN V·Filed 2011·Granted Aug 25, 2015·0 cites·21 claims
- 4644US2016244497A1Fgf21 mutants and uses thereofAMGEN INC·Filed 2016·Application pending·0 cites
- 4741US2009252703A1Use of alcohol co-solvents to improve pegylation reaction yieldsGEGG JR COLIN V·Filed 2007·Application pending·0 cites
- 4837US2005124537A1Modulators of receptors for parathyroid hormone and parathyroid hormone-related proteinAMGEN INC·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Colin Gegg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →